Definition

A preparation of autologous lymphocytes that are isolated from each patient’s tumor-draining lymph nodes and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous tumor-draining LNLs specifically recognize and kill the patient’s tumor cells.